Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short or Long Antibiotic Regimes in Orthopaedics (SOLARIO)
2022-000602-10Phase 4Active
- Sponsor
- Oxford University Hospitals
- Start
- Apr 2022
- Modality
- Antimicrobial Peptides → Native Peptides → Peptides, Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of gentamicin and vancomycin in osteomyelitis (OM), periprosthetic joint infection (PJI) and orthopedic infection (2 arms), sponsored by Oxford University Hospitals. Primary endpoint: Definitive treatment failure at 12 months. Started Apr 2022; status: active.
02
Drugs
gentamicinvancomycin
03
Conditions
osteomyelitis (OM)periprosthetic joint infection (PJI)orthopedic infection
Beyond the preview
Go deeper on 2022-000602-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-000602-10.